JAMA Dermatology: Highlights and Developments from 2025
-
By
-
Kanade Shinkai
-
May 1, 2026
By
Kanade Shinkai
May 1, 2026
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
by E. Meryl Shychuk, Elyse M. C. Harris, Lindsay A. Thompson
May 1, 2026
Health-related critiques of sunscreen were uncommon, but videos containing critique drew more audience interaction than promotion-only videos.
by Kerri Miller
June 19, 2026